Knowledge Hub: Medication-Assisted Treatment
Racial and insurance inequities persist in access to medications for opioid use disorder in the US, according to research.
Strong collaboration between physicians and SUD treatment programs provides continuity of care.
Mental health and SUD bias impact the quality of ED care that patients receive.
Opioid use disorder (OUD) and overdose rates rose during the COVID-19 pandemic.
Smartphone app-based contingency management for adult patients in OUD treatment was associated with fewer days of opioid use.
This review focused on the prevalence, care, and best practices for addressing PTSD in patients with SUD.
EDs had fewer than 1% of opioid-naïve patients given IV opioids for acute pain developed persistent opioid use.
Buprenorphine is a key medication used to treat opioid use disorder (OUD) and can reduce the risks of overdose and death.
180 Mount Airy Road Suite 205
Basking Ridge, NJ 07920
Connect
The content of this site is intended for healthcare professionals.
© 2025 Physician’s Weekly, a Formedics PropertyAny views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.